Status:
UNKNOWN
Comparison Between Letrozole and Laparoscopic Ovarian Drilling in Women With Clomiphene Resistant Polycystic Ovarian Syndrome (PCOS)
Lead Sponsor:
Cairo University
Conditions:
Infertility
Eligibility:
FEMALE
20-40 years
Phase:
PHASE3
Brief Summary
140 women with clomiphene resistant PCOS will be randomly divided into 2 equal groups using computer generated random numbers. Group 1 will receive Letrozole, group 2 will have laparoscopic ovarian dr...
Detailed Description
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive age, with an incidence of 5 -10%. Classically clomiphene citrate (CC) is the first approach to induce ovulation i...
Eligibility Criteria
Inclusion
- Clomiphene resistant PCOS women
Exclusion
- Other causes of infertility.
- Hyperprolactinaemia.
- BMI\>35.
- Previous Letrozole or LOD therapy.
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT02305693
Start Date
November 1 2014
Last Update
July 29 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
BeniSuef University hospitals
BeniSuef, Egypt
2
Cairo University Hospitals
Cairo, Egypt